Robot-assisted extended pelvic lymphadenectomy

Michael Woods, Raju Thomas, Rodney Davis, Paul E. Andrews, Robert G. Ferrigni, Joan Cheng, Erik P Castle

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Purpose: To evaluate perioperative and pathologic outcomes of patients undergoing robot-assisted extended pelvic lymphadenectomy for bladder cancer. Materials and Methods: A retrospective chart review was performed for all 27 patients who underwent robotassisted radical cystectomy (RARC) and extended pelvic lymphadenectomy at Tulane University and Mayo Clinic Arizona between March 2005 and April 2007. Baseline demographic, perioperative, and pathologic data were evaluated. The bifurcation of the aorta was the proximal border of dissection in all patients. Results: There was a total of 27 patients, and all procedures were completed laparoscopically; all urinary diversions were constructed extracorporeally in RARC patients. The mean total operative time was 400 minutes, and mean blood loss was 277 mL. All patients had transitional-cell carcinoma in the bladder cancer group. The mean total lymph node count for the RARC group was 12.3 (range 7-20). There were no intraoperative complications, and 9 (33%) patients experienced postoperative complications. Conclusions: An extended pelvic lymphadenectomy can be reliably and safely performed robotically during RARC in the management of bladder cancer. The robotic system aids in performing a meticulous dissection and in adhering to sound oncologic principles.

Original languageEnglish (US)
Pages (from-to)1297-1302
Number of pages6
JournalJournal of Endourology
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2008

Fingerprint

Lymph Node Excision
Cystectomy
Urinary Bladder Neoplasms
Dissection
Urinary Diversion
Transitional Cell Carcinoma
Intraoperative Complications
Robotics
Operative Time
Aorta
Lymph Nodes
Demography

ASJC Scopus subject areas

  • Urology

Cite this

Woods, M., Thomas, R., Davis, R., Andrews, P. E., Ferrigni, R. G., Cheng, J., & Castle, E. P. (2008). Robot-assisted extended pelvic lymphadenectomy. Journal of Endourology, 22(6), 1297-1302. https://doi.org/10.1089/end.2008.0075

Robot-assisted extended pelvic lymphadenectomy. / Woods, Michael; Thomas, Raju; Davis, Rodney; Andrews, Paul E.; Ferrigni, Robert G.; Cheng, Joan; Castle, Erik P.

In: Journal of Endourology, Vol. 22, No. 6, 01.06.2008, p. 1297-1302.

Research output: Contribution to journalArticle

Woods, M, Thomas, R, Davis, R, Andrews, PE, Ferrigni, RG, Cheng, J & Castle, EP 2008, 'Robot-assisted extended pelvic lymphadenectomy', Journal of Endourology, vol. 22, no. 6, pp. 1297-1302. https://doi.org/10.1089/end.2008.0075
Woods M, Thomas R, Davis R, Andrews PE, Ferrigni RG, Cheng J et al. Robot-assisted extended pelvic lymphadenectomy. Journal of Endourology. 2008 Jun 1;22(6):1297-1302. https://doi.org/10.1089/end.2008.0075
Woods, Michael ; Thomas, Raju ; Davis, Rodney ; Andrews, Paul E. ; Ferrigni, Robert G. ; Cheng, Joan ; Castle, Erik P. / Robot-assisted extended pelvic lymphadenectomy. In: Journal of Endourology. 2008 ; Vol. 22, No. 6. pp. 1297-1302.
@article{e42a53a834c74a4e9be13a9dd850c9d1,
title = "Robot-assisted extended pelvic lymphadenectomy",
abstract = "Purpose: To evaluate perioperative and pathologic outcomes of patients undergoing robot-assisted extended pelvic lymphadenectomy for bladder cancer. Materials and Methods: A retrospective chart review was performed for all 27 patients who underwent robotassisted radical cystectomy (RARC) and extended pelvic lymphadenectomy at Tulane University and Mayo Clinic Arizona between March 2005 and April 2007. Baseline demographic, perioperative, and pathologic data were evaluated. The bifurcation of the aorta was the proximal border of dissection in all patients. Results: There was a total of 27 patients, and all procedures were completed laparoscopically; all urinary diversions were constructed extracorporeally in RARC patients. The mean total operative time was 400 minutes, and mean blood loss was 277 mL. All patients had transitional-cell carcinoma in the bladder cancer group. The mean total lymph node count for the RARC group was 12.3 (range 7-20). There were no intraoperative complications, and 9 (33{\%}) patients experienced postoperative complications. Conclusions: An extended pelvic lymphadenectomy can be reliably and safely performed robotically during RARC in the management of bladder cancer. The robotic system aids in performing a meticulous dissection and in adhering to sound oncologic principles.",
author = "Michael Woods and Raju Thomas and Rodney Davis and Andrews, {Paul E.} and Ferrigni, {Robert G.} and Joan Cheng and Castle, {Erik P}",
year = "2008",
month = "6",
day = "1",
doi = "10.1089/end.2008.0075",
language = "English (US)",
volume = "22",
pages = "1297--1302",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Robot-assisted extended pelvic lymphadenectomy

AU - Woods, Michael

AU - Thomas, Raju

AU - Davis, Rodney

AU - Andrews, Paul E.

AU - Ferrigni, Robert G.

AU - Cheng, Joan

AU - Castle, Erik P

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Purpose: To evaluate perioperative and pathologic outcomes of patients undergoing robot-assisted extended pelvic lymphadenectomy for bladder cancer. Materials and Methods: A retrospective chart review was performed for all 27 patients who underwent robotassisted radical cystectomy (RARC) and extended pelvic lymphadenectomy at Tulane University and Mayo Clinic Arizona between March 2005 and April 2007. Baseline demographic, perioperative, and pathologic data were evaluated. The bifurcation of the aorta was the proximal border of dissection in all patients. Results: There was a total of 27 patients, and all procedures were completed laparoscopically; all urinary diversions were constructed extracorporeally in RARC patients. The mean total operative time was 400 minutes, and mean blood loss was 277 mL. All patients had transitional-cell carcinoma in the bladder cancer group. The mean total lymph node count for the RARC group was 12.3 (range 7-20). There were no intraoperative complications, and 9 (33%) patients experienced postoperative complications. Conclusions: An extended pelvic lymphadenectomy can be reliably and safely performed robotically during RARC in the management of bladder cancer. The robotic system aids in performing a meticulous dissection and in adhering to sound oncologic principles.

AB - Purpose: To evaluate perioperative and pathologic outcomes of patients undergoing robot-assisted extended pelvic lymphadenectomy for bladder cancer. Materials and Methods: A retrospective chart review was performed for all 27 patients who underwent robotassisted radical cystectomy (RARC) and extended pelvic lymphadenectomy at Tulane University and Mayo Clinic Arizona between March 2005 and April 2007. Baseline demographic, perioperative, and pathologic data were evaluated. The bifurcation of the aorta was the proximal border of dissection in all patients. Results: There was a total of 27 patients, and all procedures were completed laparoscopically; all urinary diversions were constructed extracorporeally in RARC patients. The mean total operative time was 400 minutes, and mean blood loss was 277 mL. All patients had transitional-cell carcinoma in the bladder cancer group. The mean total lymph node count for the RARC group was 12.3 (range 7-20). There were no intraoperative complications, and 9 (33%) patients experienced postoperative complications. Conclusions: An extended pelvic lymphadenectomy can be reliably and safely performed robotically during RARC in the management of bladder cancer. The robotic system aids in performing a meticulous dissection and in adhering to sound oncologic principles.

UR - http://www.scopus.com/inward/record.url?scp=46249108969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249108969&partnerID=8YFLogxK

U2 - 10.1089/end.2008.0075

DO - 10.1089/end.2008.0075

M3 - Article

C2 - 18498233

AN - SCOPUS:46249108969

VL - 22

SP - 1297

EP - 1302

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 6

ER -